Bio Aurum
Maglie
About Bio Aurum
Bio Aurum is a medical research and development company of nature-based treatments for a range of neurodegenerative diseases. Their initial focus is on exploiting the naturally occurring bioactive molecules of saffron believed to target defined pathogenic pathways in Alzheimer’s and Parkinson’s diseases. Their pipeline development is based on proprietary technology and ICH-compliant standards. To progress medicine and enhance health via nature, we combine a scientific methodology with rigorous clinical validation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $230.1K
- Funding stage: Seed
- Last round: Pre-Seed (Sep 2020)
- Website: bio-aurum.it
Industries & Categories
Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/bio-aurum-143208 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.